retatrutide fda approval timeline 2025 Status: July 2026 Update Retatrutide vs Tirzepatide Compared |

GLP-1s are just the beginning of a broader trend: high-cost, high-demand therapies that members hear about long before plans can respond

Most people describe the nausea as manageable, similar to mild motion sickness

Eating large, irregular meals can blunt GLP-1 response

Schmitz O, Russell-Jones D, Shaw J, et al

Liraglutide, a once daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycemic and weight control compared with adding rosiglitazone or placebo in subjects with type 2 diabetes (LEAD-1 SU)

The team at Mind Matters Psychiatry & Weight Loss in Longwood, Florida, specializes in evidence-based medical weight-loss programs, including GLP-1 therapies such as semaglutide and tirzepatide.